Home > Journals > Acta Vulnologica > Past Issues > Acta Vulnologica 2015 September;13(3) > Acta Vulnologica 2015 September;13(3):145-55

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Permissions

 

ORIGINAL ARTICLES   

Acta Vulnologica 2015 September;13(3):145-55

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English, Italian

Usage of Ginkgo biloba and lipoic acid in patients with diabetic ulcers

Minniti V. 1, Pietris G. 1, Barbullushi E. 1, Meccoli G. 2, Veltri A. 3, Pastore P. 1

1 University of Studies Sapienza, Rome, Italy; 2 Private practice, Rome, Italy; 3 Centro Ortopedico Regina Margherita, Rome, Italy


PDF


AIM: The authors wanted to verify the clinical effectiveness of a supplement based on lipoic acid, Ginkgo biloba and Leucoselect Phytosome in patients with foot syndrome.
METHODS: The patients were sorted into two groups. Each of the two patient groups was controlled at 7, 14, 21, 31 days and then every 30 days for eight months.
RESULTS: Clear macroscopic improvement of the ulcer with diameter reduction, total epithelialization, reduction of pCO2 from the initial value and pain reduction were observed.
CONCLUSION: The use of the Ginkgo biloba, alpha lipoic acid and Leucoselect Phytosome combination together with advanced medications, is useful in the treatment of chronic diabetic ulcers.

top of page